290 related articles for article (PubMed ID: 9025899)
1. Renal pathology in WAGR syndrome.
Ariel I; Abeliovich D; Bar-ziv J; Hochberg A
Pediatr Pathol Lab Med; 1996; 16(6):1013-21. PubMed ID: 9025899
[TBL] [Abstract][Full Text] [Related]
2. Microdissecting the genetic events in nephrogenic rests and Wilms' tumor development.
Charles AK; Brown KW; Berry PJ
Am J Pathol; 1998 Sep; 153(3):991-1000. PubMed ID: 9736048
[TBL] [Abstract][Full Text] [Related]
3. Inactivation of H19, an imprinted and putative tumor repressor gene, is a preneoplastic event during Wilms' tumorigenesis.
Cui H; Hedborg F; He L; Nordenskjöld A; Sandstedt B; Pfeifer-Ohlsson S; Ohlsson R
Cancer Res; 1997 Oct; 57(20):4469-73. PubMed ID: 9377554
[TBL] [Abstract][Full Text] [Related]
4. Cell types expressing the Wilms' tumour gene (WT1) in Wilms' tumours: implications for tumour histogenesis.
Pritchard-Jones K; Fleming S
Oncogene; 1991 Dec; 6(12):2211-20. PubMed ID: 1722569
[TBL] [Abstract][Full Text] [Related]
5. [Multicystic renal tumor in a patient with WAGR syndrome].
Braun KP; May M; Erler T; Hoschke B
Urologe A; 2007 Jun; 46(6):671-4. PubMed ID: 17295033
[TBL] [Abstract][Full Text] [Related]
6. Wilms' tumor and associated malformations; report of two cases with WAGR and Drash syndrome.
Ozbey H; Boneval C; Kapran Y; Aksöyek S; Salman T; Celik A
Eur J Pediatr Surg; 1996 Jun; 6(3):186-8. PubMed ID: 8817218
[TBL] [Abstract][Full Text] [Related]
7. Insulin-like growth factor II and WT1 transcript localization in human fetal kidney and Wilms' tumor.
Yun K; Fidler AE; Eccles MR; Reeve AE
Cancer Res; 1993 Nov; 53(21):5166-71. PubMed ID: 8221652
[TBL] [Abstract][Full Text] [Related]
8. Inactivation of WT1 in nephrogenic rests, genetic precursors to Wilms' tumour.
Park S; Bernard A; Bove KE; Sens DA; Hazen-Martin DJ; Garvin AJ; Haber DA
Nat Genet; 1993 Dec; 5(4):363-7. PubMed ID: 8298644
[TBL] [Abstract][Full Text] [Related]
9. Multipoint analysis of human chromosome 11p15/mouse distal chromosome 7: inclusion of H19/IGF2 in the minimal WT2 region, gene specificity of H19 silencing in Wilms' tumorigenesis and methylation hyper-dependence of H19 imprinting.
Dao D; Walsh CP; Yuan L; Gorelov D; Feng L; Hensle T; Nisen P; Yamashiro DJ; Bestor TH; Tycko B
Hum Mol Genet; 1999 Jul; 8(7):1337-52. PubMed ID: 10369881
[TBL] [Abstract][Full Text] [Related]
10. Insulin-like growth factor II messenger ribonucleic acid expression in Wilms tumor, nephrogenic rest, and kidney.
Yun K; Molenaar AJ; Fiedler AM; Mark AJ; Eccles MR; Becroft DM; Reeve AE
Lab Invest; 1993 Nov; 69(5):603-15. PubMed ID: 7504120
[TBL] [Abstract][Full Text] [Related]
11. Clinical characteristics and outcomes of children with WAGR syndrome and Wilms tumor and/or nephroblastomatosis: The 30-year SIOP-RTSG experience.
Hol JA; Jongmans MCJ; Sudour-Bonnange H; Ramírez-Villar GL; Chowdhury T; Rechnitzer C; Pal N; Schleiermacher G; Karow A; Kuiper RP; de Camargo B; Avcin S; Redzic D; Wachtel A; Segers H; Vujanic GM; van Tinteren H; Bergeron C; Pritchard-Jones K; Graf N; van den Heuvel-Eibrink MM;
Cancer; 2021 Feb; 127(4):628-638. PubMed ID: 33146894
[TBL] [Abstract][Full Text] [Related]
12. novH: differential expression in developing kidney and Wilm's tumors.
Chevalier G; Yeger H; Martinerie C; Laurent M; Alami J; Schofield PN; Perbal B
Am J Pathol; 1998 Jun; 152(6):1563-75. PubMed ID: 9626060
[TBL] [Abstract][Full Text] [Related]
13. Nephrogenic rests in Wilms tumor patients with the Drash syndrome.
Heppe RK; Koyle MA; Beckwith JB
J Urol; 1991 Jun; 145(6):1225-8. PubMed ID: 1851891
[TBL] [Abstract][Full Text] [Related]
14. Epigenetic changes at the insulin-like growth factor II/H19 locus in developing kidney is an early event in Wilms tumorigenesis.
Okamoto K; Morison IM; Taniguchi T; Reeve AE
Proc Natl Acad Sci U S A; 1997 May; 94(10):5367-71. PubMed ID: 9144243
[TBL] [Abstract][Full Text] [Related]
15. Increased birth weights of National Wilms' Tumor Study patients suggest a growth factor excess.
Leisenring WM; Breslow NE; Evans IE; Beckwith JB; Coppes MJ; Grundy P
Cancer Res; 1994 Sep; 54(17):4680-3. PubMed ID: 8062264
[TBL] [Abstract][Full Text] [Related]
16. Clinicopathologic features of nephrogenic rests and nephroblastomatosis.
Hennigar RA; O'Shea PA; Grattan-Smith JD
Adv Anat Pathol; 2001 Sep; 8(5):276-89. PubMed ID: 11556536
[TBL] [Abstract][Full Text] [Related]
17. Genomic imprinting and Wilms' tumor.
Moulton T; Chung WY; Yuan L; Hensle T; Waber P; Nisen P; Tycko B
Med Pediatr Oncol; 1996 Nov; 27(5):476-83. PubMed ID: 8827077
[TBL] [Abstract][Full Text] [Related]
18. Mosaic allelic insulin-like growth factor 2 expression patterns reveal a link between Wilms' tumorigenesis and epigenetic heterogeneity.
Ohlsson R; Cui H; He L; Pfeifer S; Malmikumpu H; Jiang S; Feinberg AP; Hedborg F
Cancer Res; 1999 Aug; 59(16):3889-92. PubMed ID: 10463576
[TBL] [Abstract][Full Text] [Related]
19. Imaging Characteristics of Nephrogenic Rests Versus Small Wilms Tumors: A Report From the Children's Oncology Group Study AREN03B2.
Sandberg JK; Chi YY; Smith EA; Servaes S; Hoffer FA; Mullen EA; Perlman EJ; Tornwall B; Ehrlich PF; Geller JI; Grundy PE; Fernandez CV; Dome JS; Khanna G
AJR Am J Roentgenol; 2020 May; 214(5):987-994. PubMed ID: 32160052
[No Abstract] [Full Text] [Related]
20. Molecular genetics of Wilms' tumour.
Tay JS
J Paediatr Child Health; 1995 Oct; 31(5):379-83. PubMed ID: 8554853
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]